Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics.

Area of Science:

• Biotechnology
• Molecular Diagnostics
• Cancer Research

Background:

• Cell-free DNA (cfDNA) is a crucial biomarker in cancer management.
• Efficient cfDNA extraction is vital for advancing precision medicine.
• Current methods can be time-consuming, necessitating improved techniques.

Purpose of the Study:

• To develop a rapid, centrifugation-free microfluidic chip for cfDNA extraction.
• To evaluate the chip's performance against established commercial kits.
• To validate the chip's utility in monitoring cancer biomarkers.

Main Methods:

• Development of a microfluidic chip utilizing vacuum pressure and an immiscible solvent for cfDNA extraction.
• Plasma samples were processed within 15 minutes.
• Performance was assessed based on extraction efficiency, purity, and DNA quality.
• The chip was validated for detecting mutations in HER-2 positive breast cancer patients.

Main Results:

• The microfluidic chip demonstrated comparable performance to the QIAamp kit in cfDNA extraction efficiency, purity, and quality.
• The chip successfully detected a PIK3CA mutation in a patient with advanced breast cancer and liver metastasis.
• Extraction time was significantly reduced compared to traditional centrifugation-based methods.

Conclusions:

• The developed microfluidic chip offers an efficient and rapid alternative for cfDNA extraction.
• This technology has the potential to streamline liquid biopsy workflows for cancer diagnostics and monitoring.
• The platform facilitates the development of integrated sample-to-answer systems for clinical applications.